No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Combined anti-PD-1 and anti-CTLA-4 blockade improves survival among patients with BRAF-mutated melanoma and elevated LDH

byTeddy Guo

April 14, 2021

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract: Protection from SARS-CoV-2 re-infection may be diminished among elderly individuals

RelatedReports

StudyGraphics

#VisualAbstract: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

July 9, 2025

Prognostic indicators for transarterial chemoembolization in patients with hepatocellular carcinoma with extrahepatic spread identified

AI Roundup

Nivolumab plus ipilimumab improves survival over lenvatinib or sorafenib in liver cancer

June 12, 2025

Lessons from real-world implementation of lung cancer screening

Chronic Disease

Ivonescimab improves survival in advanced non-small cell lung cancer

April 30, 2025

Significant reduction in prostate screening rates after revised guidelines

Chronic Disease

BRAFV600-mutant ctDNA as a Prognostic Biomarker in Resected Stage III Melanoma

April 28, 2025

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Post-COVID Syndrome is linked to higher mortality risk and multi-organ dysfunction

#VisualAbstract: Protection from SARS-CoV-2 re-infection may be diminished among elderly individuals

#VisualAbstract: Post-COVID syndrome associated with significant morbidity and mortality beyond respiratory illnesses

#VisualAbstract: Endoscopic surgery improves survival compared to radiotherapy in patients with locally recurrent nasopharyngeal carcinoma

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports